$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
阿斯利康BTK抑制剂阿可替尼(康可期)2023中国获批上市
2025-10-19 11:44:20
Check Details
着手淋巴瘤治疗领域,Vincerx Pharma展示自研ADC药物VIP924临床前数据
2025-10-19 11:44:20
Check Details
普乐沙福注射液的功效
2025-10-19 11:44:20
Check Details
伏立诺他的使用方法?
2025-10-19 11:44:20
Check Details
伏立诺他哪里有卖的?
2025-10-19 11:44:20
Check Details
伏立诺他可以治疗艾滋病吗?
2025-10-19 11:44:20
Check Details
伏立诺他多少钱一盒?
2025-10-19 11:44:20
Check Details
伏立诺他副作用有哪些?
2025-10-19 11:44:20
Check Details
打利妥昔单抗要注意什么?
2025-10-19 11:44:20
Check Details
普乐沙福采干成功率怎么样?
2025-10-19 11:44:20
Check Details
普乐沙福的治疗效果怎么样
2025-10-19 11:44:20
Check Details
伏立诺他怎么样?
2025-10-19 11:44:20
Check Details
1
2
...
7350
7351
7352
7353
7354
7355
7356
...
10232
10233
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Acalabrutinib in CLL/SLL Survival Expectation: ELEVATE-TN and ASCEND Long-Term PFS, OS
2
Bosutinib for CML: Time to Response, BCR-ABL Monitoring, and Molecular Remission
3
Bedaquiline for Drug-Resistant TB: 24-Week Regimen, Combination Duration, and When to Stop or Extend
4
Acalabrutinib Dosing and Combination Regimens: CLL/SLL, MCL, Safety Adjustments
5
Enzalutamide for Prostate Cancer: Managing Fatigue, Dizziness, Hypertension, and Serious Neurocardiovascular Risks
6
Bosutinib for Ph+ CML: Indications, Dosing Adjustments, and Hepatic/Renal Safety
7
Tamoxifen Long-Term Safety: Vigilance for Thrombosis and Endometrial Risks
8
Acoramidis for ATTR-CM: Disease Progression Is Not Equivalent to Drug Resistance
9
Lorlatinib Contraindications and Safety Warnings: Six Key Risks to Monitor
10
AZA+VEN+IVO Triplet Therapy for Newly Diagnosed IDH1 AML: High Response Rates and Durable Efficacy
11
Dacomitinib for EGFR-Mutant NSCLC: Dosing, Switching, and Safety Profile
12
Abemaciclib for HR+ HER2- Breast Cancer: Mechanism, Combination Therapy, and Switching Considerations